PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
04-Nov-2025 AcutePet Urgent Care Expands to South Jersey With Voorhees Opening November 7 ACCESS Newswire
04-Nov-2025 DistillerSR and Elsevier to Collaborate on the Integration of Elsevier's Embase(R) and DistillerSR's Evidence Management Platform ACCESS Newswire
04-Nov-2025 Exousia Pro Announces Breakthrough In Exosome-Based Delivery ACCESS Newswire
04-Nov-2025 Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend ACCESS Newswire
04-Nov-2025 ForCast Orthopedics Receives Qualified Infection Disease Product (QIDP) Designation From FDA for Second Pipeline Program ACCESS Newswire
04-Nov-2025 Williamsburg-Based Faith Recovery Earns CARF Accreditation ACCESS Newswire
04-Nov-2025 CASI Pharmaceuticals to Participate at Guggenheim Healthcare Innovation Conference ACCESS Newswire
04-Nov-2025 Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results ACCESS Newswire
04-Nov-2025 VSee Health Secures Three-Year Platform Services Agreement with the Region's Sole Level 1 Trauma Center and Academic Health System ACCESS Newswire
04-Nov-2025 Ignite Biomedical and Liquid Biosciences Announce the Discovery of Biomarkers for the Diagnosis and Treatment of Autism Spectrum Disorder ACCESS Newswire
04-Nov-2025 AIML Subsidiary NeuralCloud Solutions Engages Lonacas Consultants to Lead Regulatory Submission for CardioYield(TM) in Jamaica ACCESS Newswire
04-Nov-2025 Coalition for Patient Rights Announces Update on Their Inaugural Hoedown Nov. 15; Lead-Up Performance by Country Artist Jonny Hazard at Downtown Container Park Nov. 5 ACCESS Newswire
04-Nov-2025 Equitech-Bio Extends Global Reach With Bioz Badges, Showcasing Citation Engagement From Researchers ACCESS Newswire
04-Nov-2025 NAYA Therapeutics to Present at the Network for Optimized Astatine-Labeled Radiopharmaceuticals (NOAR) Europe Annual Meeting ACCESS Newswire
04-Nov-2025 BioNxt Reports "Intention to Grant" Patent Notification from the European Patent Office for Its Oral Cladribine Sublingual Thin-Film as the Multiple Sclerosis Market Shifts Toward Patient-Friendly Therapies ACCESS Newswire
04-Nov-2025 Faron Announces Two Bexmarilimab Abstracts Accepted At Ash 2025, Including An Oral Presentation On Treatment Efficacy ACCESS Newswire
04-Nov-2025 Cellbxhealth PLC Announces Expert Consensus on CTCs; Update on Funding ACCESS Newswire
03-Nov-2025 FluoGuide A/S Issue Warrants to Board Members, Executive Management and Employees ACCESS Newswire
03-Nov-2025 Protagonist Therapeutics Announces Oral and Poster Presentations on Rusfertide at the 67th Annual ASH Meeting ACCESS Newswire
03-Nov-2025 FluoGuide A/S Completes Directed Share Issue of SEK 104 Million ACCESS Newswire